Muscle Invasive Bladder Carcinoma — Trials

Muscle Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 34
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05295992	Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach(ARTIA-Vesica)	active not recruiting	N/A	110	Varian, a Siemens Healthineers CompanyINDUSTRY	1	Mar 6, 2026	clinicaltrials

Data updated 22 days agoSource updated Mar 6, 2026source: clinicaltrials